Sphera Funds Management

Summary

In 2004 was created Sphera Funds Management, which is appeared as VC. The venture was found in Asia in Israel. The leading representative office of defined VC is situated in the Tel Aviv.

Among the most popular fund investment industries, there are Health Care, Genetics. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Passage Bio, GenSight Biologics, Oncorus The fund has exact preference in a number of founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

The fund was created by Israel Mor. The overall number of key employees were 2.

Deals in the range of 50 - 100 millions dollars are the general things for fund. The increased amount of exits for fund were in 2016. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2015. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Sphera Funds Management performs on 71 percentage points more the average number of lead investments. Speaking about the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations.

The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Sphera Funds Management, startups are often financed by Versant Ventures, OrbiMed, Index Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Sanofi-Genzyme BioVentures, Perceptive Advisors. In the next rounds fund is usually obtained by Sofinnova Partners.